Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? by Mario Rotondi, Francesca Coperchini, Francesco Latrofa, Luca Chiovato

Get full text

Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases by Isabella Lupi, Alessandro Brancatella, Mirco Cosottini, Nicola Viola, Giulia Lanzolla, Daniele Sgrò, Giulia Di Dalmazi, Francesco Latrofa, Patrizio Caturegli, Claudio Marcocci

Get full text

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment by David Viola, Laura Agate, Eleonora Molinaro, Valeria Bottici, Loredana Lorusso, Francesco Latrofa, Liborio Torregrossa, Laura Boldrini, Teresa Ramone, Paolo Vitti, Rossella Elisei

Get full text

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy by Antonio Matrone, Liborio Torregrossa, Elisa Sensi, Daniele Cappellani, Walter Baronti, Raffaele Ciampi, Eleonora Molinaro, Clara Ugolini, Aleksandr Aghababyan, Luigi De Napoli, Francesco Latrofa, Gabriele Materazzi, Fulvio Basolo, Paolo Vitti, Rossella Elisei

Get full text

Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade by Alessandro Brancatella, Laura Pierotti, Nicola Viola, Isabella Lupi, Lucia Montanelli, Chiara Cremolini, Paolo Piaggi, Antonio Chella, Andrea Antonuzzo, Daniele Sgrò, Lucia Antonangeli, Chiara Sardella, Sandra Brogioni, Claudio Marcocci, Ferruccio Santini, Francesco Latrofa

Get full text

Optic Neuropathy in 2 Thyroidectomized Patients with Moderate to Severe Graves Ophthalmopathy Following L-Thyroxine Withdrawal Prior to Radioiodine Treatment for Thyroid Carcinoma by Roberto Rocchi, MD, Maria Antonietta Altea, MD, Michele Marinò, MD, Francesca Menconi, MD, Marenza Leo, MD, Eleonora Sisti, MD, Maria Antonietta Profilo, MD, Paola Lepri, MD, Marco Nardi, MD, Paolo Vitti, MD, Claudio Marcocci, MD, Francesco Latrofa, MD

Get full text